SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,419 | +70.2% | 3,295 | +60.8% | 0.03% | +80.0% |
| Q2 2023 | $234,651 | -48.8% | 2,049 | -38.4% | 0.02% | -51.6% |
| Q1 2023 | $458,698 | +6.4% | 3,328 | 0.0% | 0.03% | -6.1% |
| Q4 2022 | $431,242 | +42.8% | 3,328 | +21.7% | 0.03% | +32.0% |
| Q3 2022 | $302,000 | -50.9% | 2,734 | -24.3% | 0.02% | -67.1% |
| Q4 2020 | $615,000 | +0.5% | 3,611 | -17.2% | 0.08% | -12.6% |
| Q3 2020 | $612,000 | +7.4% | 4,360 | +22.5% | 0.09% | -2.2% |
| Q2 2020 | $570,000 | +63.8% | 3,560 | 0.0% | 0.09% | +29.0% |
| Q1 2020 | $348,000 | -17.7% | 3,560 | +8.5% | 0.07% | +1.5% |
| Q4 2019 | $423,000 | +71.3% | 3,280 | 0.0% | 0.07% | +58.1% |
| Q3 2019 | $247,000 | -41.7% | 3,280 | +17.6% | 0.04% | -43.4% |
| Q2 2019 | $424,000 | +27.7% | 2,790 | 0.0% | 0.08% | +8.6% |
| Q1 2019 | $332,000 | +89.7% | 2,790 | +73.3% | 0.07% | +66.7% |
| Q4 2018 | $175,000 | +80.4% | 1,610 | +168.3% | 0.04% | +100.0% |
| Q3 2018 | $97,000 | – | 600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |